Also known as REGN727, SAR-236553, SAR236553
Alirocumab, sold under the brand name Praluent, is a medication used as a second-line treatment for high cholesterol for adults whose cholesterol is not controlled by diet and statin treatment. It is a human monoclonal antibody that belongs to a novel class of anti-cholesterol drugs, known as PCSK9 inhibitors, and it was the first such agent to receive FDA approval. The FDA approval was contingent on the completion of further clinical trials to better determine efficacy and safety.
via PubMed
Алирокумаб — лекарственный препарат, моноклональное антитело для лечения гиперлипидемии. Одобрен для применения: ЕС, США (2015).
Abstract from DBpedia / Wikipedia · CC BY-SA
via Wikidata · CC0
via Wikidata sitelinks · CC0
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).